Analysis of Second Primary Malignancies (SPMs) in CALGB (Alliance)/ECOG/BMT CTN 100104 von Holstein, S.A, Owzar, K, Richardson, P.G, Jiang, C, Hofmeister, C.C, Hassoun, H, Hurd, D.D, Stadtmauer, E.A, Giralt, S, Devine, S.M, Hars, V, Postiglione, J, Weisdorf, D.J, Vij, R, Moreb, J.S, Callander, N.S, Pasquini, M.C, Martin, T.G, Shea, T.C, Anderson, K, McCarthy, P.L

Volltext

VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study von Chang, Julie E., Carmichael, Lakeesha L., Kim, KyungMann, Peterson, Christopher, Yang, David T., Traynor, Anne M., Werndli, Jae E., Huie, Michael S., McFarland, Thomas A., Volk, Michael, Blank, Jules, Callander, Natalie S., Longo, Walter L., Kahl, Brad S.

Volltext

Negative regulation of the tumor suppressor p53 gene by microRNAs von Kumar, M, Lu, Z, Takwi, A.A.L, Chen, W, Callander, N.S, Ramos, K.S, Young, K.H, Li, Y

Volltext

Dreamm-2: single-agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma (rrmm), including subgroups with renal impairment (ri) and high-risk (hr) cytogene... von S. Lonial, H.C. Lee, A. Badros, S. Trudel, A.K. Nooka, A. Chari, A-O. Abdallah, N.S. Callander, D.W. Sborov, A. Suvannasankha, K. Weisel, P.M. Voorhees, M. Hultcrantz, E.N. Libby, P.G. Richardson, P. Rodriguez Otero, B. Besemer, T. Facon, A. Hoos, J. Baron, T. Piontek, R.C. Jewell, E. Lewis, J. Opalinska, I. Gupta, A.D. Cohen, A. Medaglia

Volltext

Paclitaxel followed by filgrastim for peripheral blood stem cell (PBSC) mobilization in patients with hematologic malignancies who experienced prior mobilization failures von McKibbin, T., Burzynski, J.A., Twombly, R.G., Ochoa, J.L., Tsai, T.W., Callander, N.S., Freytes, C.O.

Volltext